Mariner Independent Advisor Network’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Mariner Independent Advisor Network's BMY Position: Q3 2022 in Review
Mariner Independent Advisor Network reduced its Bristol-Myers Squibb (BMY) stake by 6.8% in Q3 2022, selling an estimated $291K and leaving 55,042 shares worth $3.91M. The position accounts for 0.17% of the portfolio, ranked #143.
Mariner Independent Advisor Network first reported a position in BMY in Q4 2014 and has held it in 22 quarters since. The position peaked at $4.52M in Q2 2022. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- Mariner Independent Advisor Network held 55,042 shares of Bristol-Myers Squibb worth $3.91M as of Q3 2022.
- Mariner Independent Advisor Network sold 4,012 Bristol-Myers Squibb shares in Q3 2022, an estimated $291K.
- Bristol-Myers Squibb made up 0.17% of Mariner Independent Advisor Network's portfolio in Q3 2022, its #143 holding.
- Mariner Independent Advisor Network first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 22 quarters since.
- Mariner Independent Advisor Network's Bristol-Myers Squibb position peaked at $4.52M in Q2 2022.
- 2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on Mariner Independent Advisor Network's 13F filing for Q3 2022, filed 10 Nov 2022.